These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


294 related items for PubMed ID: 3010516

  • 1. Detection of acquired immunodeficiency syndrome (AIDS) retrovirus antibody by lymphadenopathy-associated virus (LAV) enzyme immunoassay in low- and high-risk populations.
    Ragni MV, Lewis JH, Bracken M, Toth R, Stokes J, Steffensen DO.
    Transfusion; 1986; 26(3):299-301. PubMed ID: 3010516
    [Abstract] [Full Text] [Related]

  • 2. Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood.
    Esteban JI, Shih JW, Tai CC, Bodner AJ, Kay JW, Alter HJ.
    Lancet; 1985 Nov 16; 2(8464):1083-6. PubMed ID: 2865566
    [Abstract] [Full Text] [Related]

  • 3. Performance evaluation of the Abbott HTLV III EIA, a test for antibody to HTLV III in donor blood.
    Barrett JE, Dawson G, Heller J, Bairstow C, Fico R, Webber JS, Gutierrez R, Decker RH.
    Am J Clin Pathol; 1986 Aug 16; 86(2):180-5. PubMed ID: 3017089
    [Abstract] [Full Text] [Related]

  • 4. HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia.
    Jason JM, McDougal JS, Dixon G, Lawrence DN, Kennedy MS, Hilgartner M, Aledort L, Evatt BL.
    JAMA; 1986 Jan 10; 255(2):212-5. PubMed ID: 3001375
    [Abstract] [Full Text] [Related]

  • 5. Antibodies to acquired immune deficiency syndrome (AIDS)-associated virus (HTLV-III/LAV) in Venezuelan populations.
    Volsky DJ, Rodriguez L, Dewhurst S, Sinangil F, Sakai K, Merino F, Esparza B, De Salvo L.
    AIDS Res; 1986 Jan 10; 2(2):79-92. PubMed ID: 3013223
    [Abstract] [Full Text] [Related]

  • 6. HTLV-III/LAV antibodies and virus in hemophilia patients in Nebraska: survey and initiation of a prospective study.
    Volsky DJ, Wu YT, Sinangil F, Goldsmith JC.
    AIDS Res; 1986 Feb 10; 2(1):51-61. PubMed ID: 2424467
    [Abstract] [Full Text] [Related]

  • 7. Prevalence of AIDS-associated retrovirus and antibodies among male homosexuals at risk for AIDS in Greenwich Village.
    Casareale D, Dewhurst S, Sonnabend J, Sinangil F, Purtilo DT, Volsky DJ.
    AIDS Res; 1986 Feb 10; 1(6):407-21. PubMed ID: 6085926
    [Abstract] [Full Text] [Related]

  • 8. High prevalence and high titers of LAV/HTLV-III antibodies in healthy hemophiliacs in the midwestern United States.
    Goldsmith JC, Dewhurst S, Hedenskog M, Casareale D, Volsky DJ.
    Am J Med; 1986 Oct 10; 81(4):579-83. PubMed ID: 3532787
    [Abstract] [Full Text] [Related]

  • 9. Laboratory and epidemiologic evaluation of an enzyme immunoassay for antibodies to HTLV-III.
    Ward JW, Grindon AJ, Feorino PM, Schable C, Parvin M, Allen JR.
    JAMA; 1986 Jul 18; 256(3):357-61. PubMed ID: 3014173
    [Abstract] [Full Text] [Related]

  • 10. IgM and IgG antibodies to human T cell lymphotropic retrovirus (HTLV-III) in lymphadenopathy syndrome and subjects at risk for AIDS in Italy.
    Aiuti F, Rossi P, Sirianni MC, Carbonari M, Popovic M, Sarngadharan MG, Contu L, Moroni M, Romagnani S, Gallo RC.
    Br Med J (Clin Res Ed); 1985 Jul 20; 291(6489):165-6. PubMed ID: 2990634
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC).
    MMWR Morb Mortal Wkly Rep; 1986 Mar 14; 35(10):152-5. PubMed ID: 3005822
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Radioimmunoassay and enzyme-linked immunoassay of antibodies to the core protein (P24) of human T-lymphotropic virus (HTLV III).
    Neurath AR, Strick N, Sproul P, Baker L, Rubinstein P, Stevens CE, Taylor P, Gallo RC, Gold JW, Lee YS.
    J Virol Methods; 1985 May 14; 11(1):75-86. PubMed ID: 2989312
    [Abstract] [Full Text] [Related]

  • 15. Testing for antibodies to AIDS-associated retrovirus (HTLV-III/LAV) by indirect fixed cell immunofluorescence: specificity, sensitivity, and applications.
    Hedenskog M, Dewhurst S, Ludvigsen C, Sinangil F, Rodriguez L, Wu YT, Volsky DJ.
    J Med Virol; 1986 Aug 14; 19(4):325-34. PubMed ID: 3018138
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prevalence of HTLV-III/LAV in household contacts of patients with confirmed AIDS and controls in Kinshasa, Zaire.
    Mann JM, Quinn TC, Francis H, Nzilambi N, Bosenge N, Bila K, McCormick JB, Ruti K, Asila PK, Curran JW.
    JAMA; 1986 Aug 08; 256(6):721-4. PubMed ID: 3014178
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of a new confirmatory assay for antibodies against lymphadenopathy-associated virus (LAV)/human T-lymphotropic virus type III (HTLV III).
    Abb J.
    Vox Sang; 1986 Aug 08; 51(3):233-5. PubMed ID: 3544497
    [Abstract] [Full Text] [Related]

  • 19. Anti-LAV/HTLV-III antibodies in groups of individuals at high risk for infection in Italy.
    Zanetti AR, Ferroni P, Colombo M, Cargnel A, Mari D, Zehender G, Rumi MG, Gringeri A, Ammassari M, Mannucci PM.
    Ric Clin Lab; 1985 Aug 08; 15(4):357-64. PubMed ID: 3914699
    [Abstract] [Full Text] [Related]

  • 20. Evidence against transmission of human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) in families of children with the acquired immunodeficiency syndrome.
    Kaplan JE, Oleske JM, Getchell JP, Kalyanaraman VS, Minnefor AB, Zabala-Ablan M, Joshi V, Denny T, Cabradilla CD, Rogers MF.
    Pediatr Infect Dis; 1985 Aug 08; 4(5):468-71. PubMed ID: 2995933
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.